Fitness6 months ago
Ticagrelor and aspiring dual antiplatelet therapy is favourable over monotherapy following coronary artery bypass | 2 Minute Medicine
1. Dual antiplatelet therapy with ticagrelor and asprin led to a significantly lower risk of major adverse cardiovascular events over 5 years compared to ticagrelor or...
